ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

WGS GeneDx Holdings Corporation

28,4891
-0,2909 (-1,01%)
17 Jun 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
GeneDx Holdings Corporation WGS NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,2909 -1,01% 28,4891 20:59:47
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
28,50 27,13 28,98 27,74 28,78
mais cotações »

Notícias Recentes

Data Hora Fonte Título
10/06/202409:30GLOBEGeneDx Announces Collaboration with Epic Aura to Expand..
05/06/202408:00GLOBEGeneDx Announces Patient Access Program to Expand Access to..
22/05/202417:05GLOBEGeneDx to Participate in Upcoming Investor Conferences
29/04/202417:05GLOBEGeneDx Reports First Quarter 2024 Financial Results and..
23/04/202409:30GLOBEGeneDx Announces Partnership with Komodo Health to Expand..
04/04/202417:05GLOBEGeneDx to Report First Quarter 2024 Financial Results on..
14/03/202409:30GLOBEGeneDx to Present Data at the 2024 American College of..
26/02/202418:05GLOBEGeneDx to Participate in 44th Annual Cowen Health Care..
20/02/202418:26GLOBEGeneDx Reports Fourth Quarter and Full Year 2023 Financial..
01/02/202418:30GLOBEGeneDx to Report Fourth Quarter 2023 Financial Results on..
24/01/202418:30GLOBEGeneDx Reports Inducement Grants Under Nasdaq Listing Rule..
08/01/202410:55GLOBEGeneDx Announces Preliminary 2023 Financial Results
01/12/202310:30GLOBEGeneDx Presents New Data at the American Epilepsy Society..
28/11/202318:05GLOBEGeneDx to Participate in 6th Annual Evercore ISI HealthCONx..
20/11/202318:05GLOBEGeneDx Reports Inducement Grants Under Nasdaq Listing Rule..
30/10/202317:05GLOBEGeneDx Reports Third Quarter 2023 Financial Results and..
09/10/202317:05GLOBEGeneDx to Report Third Quarter 2023 Financial Results on..
22/09/202317:05GLOBEGeneDx Reports Inducement Grants Under Nasdaq Listing Rule..
11/09/202309:00GLOBEGeneDx Announces Evolution of Executive Leadership Team
06/09/202309:00GLOBEGeneDx Announces Industry-Leading Accomplishment of 500,000..
21/08/202308:00GLOBEGeneDx Announces Data Demonstrating that Whole Exome and..
08/08/202321:05GLOBEGeneDx Reports Inducement Grants Under Nasdaq Listing Rule..
08/08/202317:05GLOBEGeneDx Reports Second Quarter 2023 Financial Results and..
07/08/202309:00PRNUSPacBio and GeneDx Launch Research Collaboration with the..
19/07/202308:05GLOBEGeneDx and Prognos Health Announce Strategic Partnership to..
18/07/202317:05GLOBEGeneDx to Report Second Quarter 2023 Financial Results on..
28/06/202308:00GLOBEGeneDx to Present New Data on Urine Mitochondrial DNA..
26/06/202317:01GLOBEGeneDx Announces New Tool to Help Harness Human Pangenome..
20/06/202308:00GLOBEGeneDx Commends the States of Arizona and Florida for Adding..

Seu Histórico Recente

Delayed Upgrade Clock